Chemicals, peptides, and recombinant proteins |
|
DMEM medium |
Invitrogen |
Cat# C11995500BT |
Gibco fetal bovine sera |
Gibco |
Cat# 10099141C |
SMM 293-TII Expression Medium |
SinoBiological |
Cat# M293TII-1L |
Sinofection Transfection Reagent |
SinoBiological |
Cat# STF02-5ML |
SMS 293-SUPI cell culture supplement |
SinoBiological |
Cat# M293-SUPI-100mL |
Polyethylenimine (PEI) |
Polysciences |
Cat# 24885-2 |
|
Antibodies |
|
Mouse anti-his mAb |
ZSGB-BIO |
Cat# TA-02; RRID:AB_2801388
|
Goat anti-Mouse IgG (H&L)-HRP conjugated |
Easybio |
Cat# BE0102; RRID:AB_2923205
|
Goat anti-Llama IgG H&L (HRP) |
Abcam |
Cat# ab112786; RRID:AB_10858603
|
410,712 APC anti-human IgG Fc |
BioLegend |
Cat# 410712; RRID:AB_2565790
|
Anti-HIS-APC, GG11-8F3.5.1, 100 tests |
Miltenyi Biotec |
Cat# 130-119-782; RRID:AB_2751840
|
M13 Bacteriophage Antibody (HRP) |
SinoBiological |
Cat# 11973-MM05T-H; RRID:AB_2857928
|
Anti-Human IgM antibody [IM260] |
Abcam |
Cat# ab200541 |
|
Critical commercial assays |
|
HisTrap HP 5 mL column |
GE Healthcare |
Cat# 17524802 |
Protein A HP 5 mL column |
GE Healthcare |
Cat#17040303 |
HiLoad 16/600 Superdex 200 pg |
GE Healthcare |
Cat# 28989335 |
Hitrap IgM purification 5×1ML |
GE Healthcare |
Cat# 17511001 |
Superose 6 Increase 10/300 GL |
GE Healthcare |
Cat# 29091596 |
NuPAGE 3–8% native PAGE |
Invitrogen |
Cat# EA03752BOX |
Series S Sensor Chip SA |
GE Healthcare |
Cat# 29104992 |
Series S Sensor Chip Protein A |
GE Healthcare |
Cat#29127556 |
|
Deposited data |
|
R14/SARS-CoV-2 RBD complex |
This paper |
PDB: 7WD1 |
S43/SARS-CoV-2 RBD complex |
This paper |
PDB: 7WD2 |
|
Experimental models: Cell lines |
|
HEK293T cells |
ATCC |
Cat# CRL-3216; RRID:CVCL_0063 |
HEK293F cells |
Gibco |
Cat# 11625-019 |
BHK-21 cells |
ATCC |
Cat# CCL-10; RRID:CVCL_1915 |
Sf9 Cells |
Invitrogen |
Cat# 11496015 |
Hi5 cells |
Invitrogen |
Cat# B85502
|
Vero cells |
ATCC |
Cat# CCL-81; RRID:CVCL_0059 |
|
Bacterial and virus strains |
|
Escherichia coli (E. coli) strain DH5α |
Vazyme |
Cat# C502-02 |
Live SARS-CoV-2 prototype strain hCoV-19/China/CAS-B001/2020 |
This paper |
GISAID: EPI_ISL_514256-7 |
Live SARS-CoV-2 prototype BetaCoV/Wuhan/IVDC-HB-envF13/2020 |
This paper |
GISAID: EPI_ISL_408511 |
Live SARS-CoV-2 Beta strain |
This paper |
NPRC 2.192100004 |
Live SARS-CoV-2 BA.1 strain |
This paper |
NPRC 2.192100007 |
Live SARS-CoV-2 BA.2 strain |
This paper |
NPRC 2.192100010 |
Live SARS-CoV-2 BA.4 strain |
This paper |
NPRC 2.192100012 |
Live SARS-CoV-2 BA.5 strain |
This paper |
NPRC 2.192100014 |
|
Experimental models: Organisms/strains |
|
SPF BALB/c mice, female, 6–8 weeks |
Vital River (Beijing, China) |
Cat# 01011 |
SPF K18-hACE2 mice, female, 6–8 weeks |
GemPharmatech Co., Ltd (Jiangsu, China) |
Strain NO. T037657 |
|
Recombinant DNA |
|
pCAGGS |
MiaoLingPlasmid |
Cat# P0165 |
pMES4 |
Addgene |
Cat# 154837 |
pEGFP-N1 |
MiaoLingPlasmid |
Cat# P0133 |
pFastbac1 |
Invitrogen |
Cat# 10360014 |
Prototype RBD, residues 319-541 |
This paper |
GenBank: MN908947
|
Prototype RBD with N501Y mutation, residues 319–541 (Alpha) |
This paper |
N/A |
Prototype RBD with K417N, E484K, N501Y mutation, residues 319–541 (Beta) |
This paper |
N/A |
Prototype RBD with K417T, E484K, N501Y mutation, residues 319–541 (Gamma) |
This paper |
N/A |
Prototype RBD with L452R, T478K mutation, residues 319–541 (Delta) |
This paper |
N/A |
Prototype RBD with K417N, L452R, T478K mutation, residues 319–541 (Delta plus) |
This paper |
N/A |
Prototype RBD with L452R, E484Q mutation, residues 319–541 (Kappa) |
This paper |
N/A |
Prototype RBD with L452Q, F490S mutation, residues 319–541 (Lambda) |
This paper |
N/A |
prototype RBD with R346K, E484K, N501Y mutation, residues 319–541 (Mu) |
This paper |
N/A |
Omicron BA.1 RBD, residues 319-541 |
This paper |
GISAID: EPI_ISL_6640916 |
Omicron BA.2 RBD, residues 319-541 |
This paper |
GISAID: EPI_ISL_9652748 |
Omicron BA.2 RBD with L452Q, residues 319–541 (BA.2.12.1) |
This paper |
N/A |
Omicron BA.2 RBD with D339H, G446S, N460K, R493Q, residues 319–541 (BA.2.75) |
This paper |
N/A |
Omicron BA.3 RBD, residues 319-541 |
This paper |
GISAID: EPI_ISL_7605589 |
Omicron BA.4/5 RBD, residues 319-541 |
This paper |
GISAID: EPI_ISL_12029894 |
SARS-CoV RBD, residues 306-527 |
This paper |
GenBank: NC_004718
|
RaTG13 RBD, residues 319-541 |
This paper |
GenBank: QHR63300.2
|
RshSTT182 RBD, residues 319-541 |
This paper |
GISAID: EPI_ISL_852604 |
RacCS203 RBD, residues 319-541 |
This paper |
GenBank: QQM18864.1
|
Rc-o319 RBD, residues 319-541 |
This paper |
GenBank: BCG66627.1
|
RsYN04 RBD, residues 309-527 |
This paper |
GISAID: EPI_ISL_1699444 |
GX/P2V/2017 RBD, residues 319-541 |
This paper |
GISAID: EPI_ISL_410542 |
GD/1/2019 RBD, residues 319-541 |
This paper |
GISAID: EPI_ISL_410721 |
|
Software and algorithms |
|
FlowJo V10 |
FLOWJO |
https://www.flowjo.com/solutions/flowjo/downloads |
Graphpad Prism 7 |
GraphPad Software |
https://www.graphpad.com/ |
BIAcore® 8K Evaluation software |
GE Healthcare |
N/A |
PKSolver |
Zhang et al.41
|
N/A |
HKL2000 |
Otwinowski et al.42
|
https://www.hkl-xray.com/hkl-2000 |
Phaser |
Read R.J. et al.43
|
N/A |
COOT |
Emsley et al.44
|
http://www.mrc-lmb.cam.ac.uk/personal/peemsley/coot/ |
Phenix |
Adams et al.45
|
http://www.phenix-online.org/ |
MolProbity |
Williams et al.46
|
http://molprobity.biochem.duke.edu/index.php |
PyMOL software |
Molecular Graphics System, Version 1.8 Schrö dinger |
https://pymol.org/2/ |